JINGZHOU YONGTAIHENG ENTERPRISE

The company highlights the investment in new drug research and development and patented technology, and it has made a series of major achievements. It owns 12 new drug certificates and 15 patents. The company drafts 15 national standards about drugs. Through continuous research & development and accumulation, its products include proton pump inhibitor products such as omeprazole sodium and lansoprazole, nervous system drugs such as sodium aescinate, antibiotic based drugs such as clindamycin and levofloxacin, antiviral agents such as acyclovir and ganciclovir, and cephalosporin series such as cefuroxime sodium and ceftizoxime.